Comparison of Early Operative Treatment and 48 h Conservative Treatment in Small Bowel Obstruction
NCT ID: NCT03139149
Last Updated: 2023-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2017-10-11
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short and Prolonged Conservative Treatment in Patients With Adhesive Intestinal Obstruction
NCT05841069
PReventive cOlostomy vs Ileostomy in Low anTErior reCTal Resection
NCT04357171
Radiologic Score and Failure of Conservative Management of Adhesive Small Bowel Obstruction
NCT05517057
Small Bowel Obstruction in Virgin Abdomen
NCT06912581
Small Bowel Obstruction and Surgery
NCT03826251
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early surgery
After exclusion of indications for an emergency operation, conservative treatment is performed up to 12 hours from the moment of admission. Each patient receive blood test, blood lactate investigation, blood biochemistry, X-ray of the abdomen, ultrasound and CT on the admission. Each patient receive water-soluble contrast in 3 h after admission. In case of of clinical and radiologic signs of obstruction in 12 h after admission, surgery is performed. On the first stage of surgical treatment laparoscopic adhesiolysis is performed. If it is impossible to eliminate the cause of obstruction by laparoscopic technique laparotomy is performed.
Adhesiolysis
Method of video laparoscopic operation:
* Open access in the left upper quadrant of the anterior abdominal wall,
* Installation of trocars, depending on the prevalence of the adhesion process
* Assessment of the peritoneal adhesion index
* Detection of the asleep gut
* Detection of obstacle area
* Removing the obstacle without trying to completely eliminate the adhesion process in the abdominal cavity
If there is no possibility to eliminate the cause of intestinal obstruction laparoscopically laparotomy is performed.
X-ray diagnostics
X-ray of the thoracic (1) and abdomen (2-5 times) with water soluble contrast.
Computer tomography
Computer tomography of abdomen with iv contrast
Ultrasound
Ultrasound of the abdomen (2 times)
General and biochemical blood test
General blood test and biochemical blood test 2 times a day
Late surgery
After exclusion of indications for an emergency operation, conservative treatment is performed up to 48 hours from the moment of admission. Each patient receive blood test, blood lactate investigation, blood biochemistry, X-ray of the abdomen, ultrasound and CT on the admission. Each patient receive water-soluble contrast 3 h after admission. In case of present of obstruction and absence of contrast in colon in 36 h after intake (48 h after admission) a surgery is perform. On the first stage of surgical treatment laparoscopic adhesiolysis is performed. If it is impossible to eliminate the cause of obstruction by laparoscopic technique laparotomy is performed.
Adhesiolysis
Method of video laparoscopic operation:
* Open access in the left upper quadrant of the anterior abdominal wall,
* Installation of trocars, depending on the prevalence of the adhesion process
* Assessment of the peritoneal adhesion index
* Detection of the asleep gut
* Detection of obstacle area
* Removing the obstacle without trying to completely eliminate the adhesion process in the abdominal cavity
If there is no possibility to eliminate the cause of intestinal obstruction laparoscopically laparotomy is performed.
X-ray diagnostics
X-ray of the thoracic (1) and abdomen (2-5 times) with water soluble contrast.
Computer tomography
Computer tomography of abdomen with iv contrast
Ultrasound
Ultrasound of the abdomen (2 times)
General and biochemical blood test
General blood test and biochemical blood test 2 times a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adhesiolysis
Method of video laparoscopic operation:
* Open access in the left upper quadrant of the anterior abdominal wall,
* Installation of trocars, depending on the prevalence of the adhesion process
* Assessment of the peritoneal adhesion index
* Detection of the asleep gut
* Detection of obstacle area
* Removing the obstacle without trying to completely eliminate the adhesion process in the abdominal cavity
If there is no possibility to eliminate the cause of intestinal obstruction laparoscopically laparotomy is performed.
X-ray diagnostics
X-ray of the thoracic (1) and abdomen (2-5 times) with water soluble contrast.
Computer tomography
Computer tomography of abdomen with iv contrast
Ultrasound
Ultrasound of the abdomen (2 times)
General and biochemical blood test
General blood test and biochemical blood test 2 times a day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
17 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pirogov Russian National Research Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander E. Tyagunov
MD. Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Moscow Clinical Hospital 1
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14121729
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.